Century Therapeutics
IPSC· Manufacturing· Fiscal year ends in December
No proxy on file names the CEO of Century Therapeutics.
Executives3
See all- 1Gregory RussottiChief Technology and Manufacturing Officer and former Interim President and Chief Executive OfficerFY2023
- 2Adrienne FaridPh.D., Former Chief Development OfficerFY2023
- 3Chad CowanPh.D., Chief Scientific OfficerNot disclosed
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allCentury Therapeutics paid its 3 named executives $6.5M in total in FY2023 (Dec).
| Name | ||
|---|---|---|
| Gregory RussottiChief Technology and Manufacturing Officer and former Interim President and Chief Executive Officer | Not disclosed | |
| Adrienne FaridPh.D., Former Chief Development Officer |
of each named executive, from the Summary Compensation Table of each proxy.
Peers
No disclosed peer group
No proxy on file names a pay peer group for Century Therapeutics. The peer group comes from the proxy statement, so it shows here when a proxy read has it.
Activity
Filings6
See all| Proxy statement | DEF 14A | Apr 27, 2026 | FY2025 |
| Annual report | 10-K | Mar 12, 2026 | FY2025 |
| Proxy statement | DEF 14A | Apr 22, 2025 | FY2024 |
| Annual report | 10-K | Mar 19, 2025 | FY2024 |
| Proxy statement | DEF 14A | Apr 26, 2024 | FY2023 |
| Annual report | 10-K | Mar 14, 2024 | FY2023 |
